Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.825 USD | -5.51% | +22.31% | +174.15% |
Business Summary
Number of employees: 296
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Dermatological Treatments
100.0
%
| 4 | 100.0 % | 60 | 100.0 % | +1,517.09% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 4 | 100.0 % | 60 | 100.0 % | +1,517.09% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 56 | 15-12-31 |
Rajvir Madan
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-31 |
Jay Ramsinghani
COO | Chief Operating Officer | - | 20-05-26 |
Patrick Burnett
CTO | Chief Tech/Sci/R&D Officer | 52 | 20-07-31 |
Courtney Barton
CMP | Compliance Officer | 41 | 21-02-17 |
Howard Welgus
BRD | Director/Board Member | 72 | 15-12-31 |
Ayisha Jeter
SAM | Sales & Marketing | - | 20-05-31 |
Tood Tucker
HRO | Human Resources Officer | - | 20-06-30 |
Jessica Robison
AUD | Comptroller/Controller/Auditor | - | 18-12-31 |
Bruce Binkowitz
PRN | Corporate Officer/Principal | - | 21-08-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Heron
CHM | Chairman | 53 | 16-03-31 |
Founder | 69 | 16-05-31 | |
Keith Leonard
BRD | Director/Board Member | 62 | 21-09-01 |
Halley Gilbert
BRD | Director/Board Member | 54 | 20-04-30 |
Howard Welgus
BRD | Director/Board Member | 72 | 15-12-31 |
Terrie Curran
BRD | Director/Board Member | 55 | 20-11-01 |
Todd Watanabe
CEO | Chief Executive Officer | 56 | 15-12-31 |
Sue-Jean Lin
BRD | Director/Board Member | 65 | 21-06-08 |
Director/Board Member | 37 | 22-09-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 115,764,164 | 113,251,140 ( 97.83 %) | 0 | 97.83 % |
Company contact information
Arcutis Biotherapeutics, Inc.
3027 Townsgate Road Suite 300
91361, Westlake Village
+
http://www.arcutis.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+174.15% | 1.08B | |
+18.12% | 124B | |
+17.78% | 111B | |
-11.49% | 23.17B | |
+5.07% | 22.94B | |
-39.94% | 17.42B | |
-10.10% | 17.42B | |
-14.97% | 16.9B | |
+2.45% | 13.71B | |
+28.28% | 11.82B |
- Stock Market
- Equities
- ARQT Stock
- Company Arcutis Biotherapeutics, Inc.